The SOX2 pathway, which is associated with stem cell characteristics and involved in embryonic development (81), and the Wnt pathway that is associated with the epithelial to mesenchymal transition (82), were both activated after endocrine treatment of ER+ breast cancer cells. Here, ESR1 is linked to breast carcinoma.